The decline in applications for infectious diseases (ID) fellowships has been an area of active introspection for the leadership of the Infectious Disease Society of America (IDSA). This prompted actions to address the problem, including surveys of current and former fellows. Ironically, the decline in applications to ID programs is occurring at a time when the need for ID providers has never been greater and the excitement and variety in the practice of ID has never been higher. Data regarding the current ID workforce are presented here, along with perspectives about the future of the profession in the decades to come.
health systems and payers, leading to disparities in reimbursements for services provided by ID specialists relative to other specialties in medicine. This has led to a reduction of applicants to ID training programs over the years, ironically occurring as the need for ID providers is poised to explode over the next several decades.
THE CURRENT LANDSCAPE: RESULTS OF THE INFECTIOUS DISEASES WORKFORCE STUDY
The National Residency Match Program (NRMP) Specialties Matching Service (SMS) is the key process by which internal medicine (IM) and pediatric subspecialty fellowship programs recruit fellows and physicians are matched with a program. Although not all entrants into a subspecialty are selected and matched through the SMS, an analysis of those who participated in the SMS provides a good picture of those entering the specialty as well as the level of interest in the specialty.
Over the last several years, the results of the NRMP SMS have been a cause for alarm because the number of applicants to adult ID fellowship programs has declined, whereas the number of positions has increased. In 2010, there were 342 applicants for 300 positions (1.14 ratio of applicants to positions); by 2014 the number of applicants had declined to 254 as the number of positions had increased to 327 (0.77 ratio). In that same year, 99 positions in 70 programs were unfilled [1] .
The decrease in applicants to ID fellowships has been in contrast to the overall experience in IM, where the total number of physicians completing IM residency training increased during the same period. The net effect is that the share of IM residency graduates applying for ID positions dropped from 5.1% in 2009-2010 to 3.2% in 2016-2017 [1] . The experience of ID in the SMS is also at odds with most other IM subspecialties. Whereas ID filled 65% of their positions in the 2016-2017 SMS, 6 of the other IM subspecialties matched >90% of their positions, with 5 of them matching >97% [1] . Although pediatric ID has not experienced the acute decline in applicants that adult ID has, the ratio of pediatric ID applicants per position has been <1 for many years; thus this specialty has struggled as well.
In response to these challenges, in 2014 the IDSA convened the Task Force for Recruitment into ID to investigate ways to increase interest in ID among the best and brightest students and residents and make recommendations regarding recruitment strategies. In October 2015, IDSA's board of directors approved the adoption of an "all-in" match policy beginning with the 2016 match cycle. This policy change was adopted to provide applicants the opportunity to fully evaluate all programs before making their selection, thus allowing applicants to determine the program that best suits their needs. Similarly, this allowed the programs to compete equally for the available applicants. Coincident with this change, the number of applicants increased dramatically, which led to a significant decrease in the number of unfilled positions. In 2015, the year before the all-in match, the number of applicants declined to 229, whereas the number of fellowship positions increased to 335 (0.68 ratio), with 117 unfilled positions in 82 programs [1] . After the all-in change, the number of applicants rose to 335 for 392 positions (0.85 ratio), with 80 unfilled positions in 54 programs [2] . Although these data demonstrate a significant improvement from prior years, it remains unclear how much of this improvement can be attributed to the all-in match. It is unlikely that it accounts for all of these gains.
In 2015 an IDSA/George Washington University Health Workforce Institute survey of ID fellows completing their training in 2016 was conducted. (The entire study can be accessed by members of the society through the IDSA website: http://www. idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/ Current_Topics_and_Issues/Workforce_and_Training/ Background/FULL Report On ID Fellows Completing Training in 2016.pdf) The results of the survey are provided in Table 1 . From the 447 fellows invited to participate, 330 responses were received (response rate = 73.8). Approximately half (46%) of the graduates in adult ID reported having difficulty finding a satisfactory position. The job market is significantly limited in areas around academic medical centers, but jobs are readily available in other areas in the United States. Most graduating fellows do not seem ready to move to medium-sized or small cities and rural communities, even though positions with better incomes are available. The average expected income for US medical graduates in ID was less for women than men; this was not true for international medical graduates (IMGs). Despite the reported income disparity, satisfaction with the salaries was identical by sex (about 70%).
International medical graduates report more difficulty securing positions, perhaps reflecting a requirement for many IMGs with temporary visas to practice in a federally designated primary care health professional shortage area in order to stay in the United States. This may discourage IMG residents from selecting an ID fellowship. Despite these limitations, IMGs often find positions with the highest salaries, resulting in an average income higher than US medical and osteopathic school graduates, likely reflecting the increased compensation offered in smaller communities trying to attract applicants.
Pediatric ID graduates are entering an even more challenging job market, both in terms of opportunity and salary support. Although a majority of pediatric ID fellows are passionate about their specialty, the job market for them is limited, and incomes are relatively low. Sixty-eight percent (68%) of pediatric fellows report having a difficult time finding a satisfactory position: 89% of respondents felt that there were few, very few, or no jobs in their local job market; 65% were expecting to work >50 hours per week; and 53% were very or somewhat dissatisfied with their expected income.
Graduating pediatric ID fellows perceive that the national job market is better than the local job market. The most common reason cited for having a difficult time finding a job was the lack of opportunities in desired locations. No fellows planned to practice in small cities or rural areas. The job market in the Northeast appears particularly tight, with 82% of respondents reporting difficulty finding a satisfactory position, 64% reporting having to change their plans, and 100% reporting there were no, very few, or few jobs in the local market and that the average income was lower than the national average. Female pediatric graduates made less than their male counterparts, had a harder time finding a satisfactory position (76% vs 43%), and were more likely to be very dissatisfied with their income (42% vs 0%). Nearly all of the fellows with committed practice plans were going to work as an employee of a hospital (67%) or at a medical school (28%).
Despite the obvious challenges faced by new ID physicians, most would recommend the specialty to medical students and residents (86% adult ID; 81% pediatric ID). Those who commented why they would recommend the specialty highlighted the intellectual challenges of the specialty, the importance and impact of ID, and their passion for the field. The decline in applications for ID fellowships has prompted active introspection into the causes. A 2016 survey of graduating IM residents indicated that financial considerations were a key factor in the decision to seek a career option other than ID [2] . The survey revealed that those initially interested in ID ultimately chose go into internal medicine/primary care, hospital medicine, and pulmonary/critical care. The trainees reported that if the ID salary were equivalent to that in their chosen field, they might have chosen ID instead. The second most common factor affecting whether to go into ID was increased exposure to ID during training. Mentorship, scholarship, and conference attendance were important factors in all career choices, regardless of subspecialty choice. These data, which are presented in more detail later in this supplement (Bonura and Armstrong), underscore the importance of salary enhancement and increased quantity and quality of exposure to microbiology and clinical ID during medical school and IM residency [3] .
Recruitment to ID remains a major focus, in large part because of the growing demand for ID-trained specialists. Recent developments in antimicrobial stewardship (AS) ensure that the need for ID specialists specifically trained in AS is substantial; this is a relatively new area of need. The human immunodeficiency virus (HIV) epidemic, now in its 36th year, still requires input from ID providers, although the role for ID in routine practice has evolved, especially over the last decade as treatment of HIV has led to a greater number of patients surviving with HIV.
INFECTIOUS DISEASES WORKFORCE AND ANTIMICROBIAL STEWARDSHIP
Antimicrobial stewardship programs have been promoted by the US Centers for Disease Control and Prevention (CDC), IDSA, the Society for Healthcare Epidemiology of America (SHEA), and the Pediatric Infectious Diseases Society (PIDS) for many years. The evidence behind the value of such programs in driving rational antimicrobial use and improving patient outcomes is clear. Antimicrobial stewardship programs are needed both in hospitals and across the continuum of care to manage the ever-growing threat of antimicrobial resistance. IDSA, SHEA, and PIDS issued joint policy statements regarding AS programs, the most recent (2014) of which makes the following 5 recommendations [4]:
1. Antimicrobial stewardship programs should be required through regulatory mechanisms. 2. Antimicrobial stewardship should be implemented and monitored in ambulatory healthcare settings. 3. Improved education about antimicrobial resistance and AS must be accomplished.
4. Antimicrobial use data should be collected and readily available for both inpatient and outpatient settings. 5. Research on AS is needed. Included within the first recommendation is the requirement that the stewardship team be physician directed or supervised. Infectious diseases physicians have generally held this position owing to their clinical ID, antimicrobial, and microbiology knowledge, which is essential to AS. The Society of Infectious Diseases Pharmacists and the American Society of HealthSystem Pharmacists published a commentary in 2016 on AS, declaring that programs optimally should include physicians with ID training as part of the program's leadership [5] .
IDSA and SHEA have developed guidance on critical elements of AS programs and their implementation [6] . This guidance is key to all programs, including those in their infancy to well-established programs that have lacked the necessary leadership to implement interventions. In 2014, the CDC recommended the implementation of AS programs in all acute-care hospitals. To that end, the CDC published several guidance documents outlining core elements of AS programs in various settings-hospitals, nursing homes, and outpatient settings. For acute-care hospitals, the CDC identified 7 core elements that should be in place in every AS program (summarized in Table 2 ) [7] . Despite such guidance, uptake of AS programs by hospitals has been inconsistent. Antimicrobial stewardship programs have been in existence in larger, academic institutions or institutions where there is an ID physician with a particular interest in AS; however, some hospitals have only rudimentary programs, some lack physician leadership, and others have few evidence-based interventions in place and no monitoring of outcomes. In 2015, only 48.1% of US hospitals had an AS program that included all 7 core elements. States' compliance ranged from a high of 70% for California to a low of 7% for Vermont. There was also variability seen by hospital size and type. Interestingly, California initially passed legislation in 2006 requiring hospitals to have an AS program. By 2014, 50% of hospitals had established an AS program; however, what 
taken by the facility. This is the first time that a stewardship program is being mandated at the federal level. A similar regulation is being prepared by the Centers for Medicare and Medicaid Services for acute-care hospitals (a draft proposal was posted in the Federal Register for comment in 2016; it is being redrafted by the new administration).
During this period, the Joint Commission was drafting a new medication management AS standard (MM.09.01.01) [8] . The new standard, which became effective 1 January 2017 for hospitals, critical access hospitals, and nursing care centers, has 8 elements of performance, 1 of which incorporates the CDC's 7 core elements for an AS program. Another element of performance requires there to be a multidisciplinary AS team that includes an ID physician "when available in the setting. "
There are >5000 acute-care hospitals and approximately 15 000 nursing homes in the United States. With each facility now required to have an AS program, it is easy to see how there are not enough trained ID physicians to lead a program in each facility. Not every facility needs to have its own unique ID physician leader, however; some facilities are quite small, and multiple facilities could be led by a single ID physician implementing telehealth to remotely lead programs and interface with trained pharmacists on site. Networks of ID physicians could provide services to multiple facilities, as is done by the Duke Antimicrobial Stewardship Outreach Network (DASON), which helps community hospitals address antimicrobial use by assisting with data collection and analysis, education, and expert consultation [9] .
The immediate need for ID physicians to fill these roles and sustain support of AS programs across multiple healthcare settings is a growing concern. Yet, the lack of ID physicians required to meet the newer mandates is not the only gap-the necessary training also needs to be addressed. Recommendations for the knowledge and skills needed to lead an AS program have been published [10] . Some of the knowledge areas are well covered during ID fellowship, particularly common infectious syndromes, microbiology, laboratory diagnostics, antimicrobial use, and pharmacokinetics and pharmacodynamics; in some fellowship programs, the general principles of AS are included in training. Infectious diseases fellows are less likely to have received training or education in the following areas: approaches to stewardship interventions, measurement and analysis, informatics/information technology, program building, special populations and nonacute hospital settings, infection prevention, and leadership skills. The latter is particularly important for individuals leading a program if they have not had other leadership experience. They need to be adept at communication and conflict resolution with a variety of stakeholders, be able to adapt stewardship efforts to evolving strategic initiatives of the institution, set goals, write reports and present data detailing interventions and improvements in patient safety, provide education, interface with patient safety and quality improvement groups, and use implementation science and change theory to develop interventions and improve practice [10] .
We also need to consider how to provide training to ID physicians already in practice who are new to the field of AS. Currently, an IDSA-supported AS curriculum is under development that can be used by all ID training programs for fellow education. The curriculum will have both a core component designed for all trainees and an advanced curriculum, which will help the interested trainee develop the unique skills needed to lead an AS program.
Leading and participating in AS programs is just 1 of a growing list of opportunities for ID providers. Effective program leadership from ID physicians is critical, and they should have protected paid time to lead the program in order to maximize its success with improved patient outcomes. New requirements and mandates for AS programs, scheduled for release in 2017, are likely to expand to include other healthcare settings (eg, acute-care hospitals, ambulatory care centers, and dialysis centers). This is an opportunity for growth of our specialty. Regulation may be our friend in this case if we can meet the needs of all of the new and existing AS programs that will result.
THE FUTURE ROLE OF INFECTIOUS DISEASE SPECIALISTS IN THE HIV WORKFORCE
On 5 June 1981, 5 cases of Pneumocystis pneumonia were reported from 3 hospitals in Los Angeles [11] . These cases heralded the beginning of the AIDS pandemic, which has become the most impactful and sustained epidemic of our generation. Through heroic efforts of many, including ID clinicians, epidemiologists, and scientists, HIV was discovered as the causative agent, the natural history of HIV and the common means of transmission were elucidated, and ultimately the first antiretroviral agents to treat the infection were released. Since then, HIV has been transformed from a death sentence into a chronic, manageable condition, representing one of the most remarkable transformations of an infectious disease in a very short period of time.
Infectious diseases investigators and clinicians were called into action early on in the epidemic, although most established researchers and providers had very little capacity to take on such an explosive epidemic at the time. This meant that the burden to fill this need fell on junior investigators, with guidance from a few senior investigators experienced in the study of viral infections. For these younger investigators, this devastating outbreak represented a call to action. Many of those in training at the time had been concerned about where they could establish their niche, especially when some venerable leaders in the field claimed (prior to the development of AIDS) that "the bell tolls for Infectious Diseases. " [12] The clinical challenges of HIV medicine were substantial, engaging providers in the treatment of myriad concomitant opportunistic infections, most of which had rudimentary treatments and limited diagnostics. The science of HIV medicine was engaging, encompassing a vast array of disciplines, including basic virology, immunology, viral pathogenesis, molecular diagnostics, drug discovery, and clinical trials. And perhaps most important, battling the HIV epidemic became a cause. The disease impacted people of the physicians' own generation, most of whom were discriminated against owing to their sexual orientation or station in life. Taken together, it was a perfect storm of need and opportunity, and it drew many of the best and brightest of the ID community to it.
WORKFORCE NEEDS IN THE EARLY AIDS ERA
As the number of cases of AIDS exploded from the few case reports in the summer of 1981 to >100 000 cases by 1990, there were not enough ID specialists to provide care in inpatient settings, much less address the growing need for outpatient care. Employing an "all hands on deck" mentality, physicians from many disciplines (IM, family medicine, pediatrics, and hematology/oncology) were enlisted to provide care for the rapidly growing HIV patient population.
By the early 1990s, most ID training programs had established highly functional, and in many ways, ideal HIV outpatient facilities that provided outstanding clinical care and rich training opportunities for patient care, as well as in clinical trials and methodologies in translational pathogenesis research. With the establishment of the Ryan White Care Act in 1990, most of these clinics became true medical "homes, " whereby patients attending the clinics could receive comprehensive, team-based care oriented toward a patient-centered clinical experience [13] .
For many of these programs, the HIV training experience was "the draw" to help recruit ID trainees.
Yet, despite the increased draw to ID, the ID workforce remained inadequate to fill the needs of the clinical demand for care. Many clinics established HIV specialists from traditionally trained primary care providers. A model emerged whereby ID-trained physicians worked together with non-ID-trained physicians and advanced practice providers to provide care. The ID specialists continued to provide expert consultation to their colleagues on the management of opportunistic infections and complex antiretroviral clinical challenges, mostly involving highly drug-resistant HIV variants within the outpatient and inpatient settings.
WORKFORCE NEEDS DURING THE HIV TREATMENT REVOLUTION
The HIV treatment revolution that occurred between 1995 and 2005 changed forever the clinical course of HIV infection. Triple-drug antiretroviral therapy transformed HIV into a chronic manageable condition whereby those infected with the virus could lead near-normal lifespans [14] . As a bonus, those who successfully sustained virologic suppression did not transmit the virus to others via sexual contact [15, 16] .
Owing to the effectiveness of antiretroviral therapy, the prevalence of individuals living with HIV has risen by approximately 30 000 per year in the United States. The majority (approximately 80%) of those engaged in care have undetectable viral loads. In such circumstances, the patients, as they grow older, encounter the same chronic conditions as the non-HIV-infected population, although some of these conditions tend to occur at a younger age among virologically controlled HIVinfected individuals. Therefore, the care of HIV patients over the last decade has become more and more similar to the provision of primary care of non-HIV-infected persons [17] . Yet the need for specialized ID/HIV expertise remains, predominantly in the following instances:
1. When newly diagnosed patients present with traditional opportunistic infections; 2. In the management of complications of antiretroviral therapy; 3. In the setting of virologic failure, which typically occurs owing to poor adherence to antiretroviral treatment; 4. In the management of longer-term complications unique to HIV, including peripheral neuropathy, neurocognitive disorders, and other dysfunction typically associated with long-standing HIV infection that was previously treated incompletely in the past; 5. In the treatment of concomitant sexually transmitted infections that are increasing at alarming rates among successfully treated HIV patients; and 6. In the implementation of best practices in international settings.
THE ROLE OF THE INFECTIOUS DISEASES SPECIALIST IN THE MODERN HIV TREATMENT ERA
With the engagement of primary care physicians in the provision of care to HIV-infected patients and the widespread use of nonphysician providers, including certified registered nurse practitioners and physician assistants, the medical home model is thriving. At the same time, the specialized ID-related HIV workforce is dwindling. A study evaluating the workforce in 2013-2014 showed that the majority of ID/HIV specialists were older (approximately 50% aged >50 years), with 11% of them planning to retire in the next 5 years [18, 19] . Although the estimates of new providers entering the workforce exceeded the projected loss over the next 5 years, the net gain of 190 new providers was deemed insufficient to meet the growth in patient care needs into 2019. Based on all of these factors, the role of the ID specialist in some HIV practices may transition to a consultative, supervisory, and teaching role. However, for those ID providers interested in primary HIV care, the opportunity to develop longitudinal relationships with patients, to engage in implementation science with alternative and innovative models of care delivery designed to maximize retention in care, and to participate in advocacy around social justice locally and nationally while serving an often vulnerable population remains highly compelling. Critically, the experiences in the exam room often fuel discovery from the clinic to the bench and often back to the clinic in the form of clinical trials.
The workforce estimates underline the need to continue to recruit ID-trained physicians interested in the full spectrum of HIV practice. For others who are more oriented toward providing expertise limited to the nuances of antiretroviral therapy, drug resistance, and the treatment of specific opportunistic infections, clinics can and should develop a model of care whereby the specialized expertise of ID-trained physicians is used in efficient and effective ways within the routine flow of patient care in the clinic. Infectious diseases training programs must continue to provide didactic and practical experience in HIV care, just as they do for treatment of bacterial, viral, parasitic, and fungal infections, recent solid organ and bone marrow transplants, and sexually transmitted infections, in the inpatient and outpatient settings. As with these other disciplines, trainees can elect to develop deeper expertise in HIV care. Their work can include domestic HIV care or delivery of care in international settings, where demand for specialized HIV care remains high. Those trainees with academic interests in HIV medicine will continue to have ample opportunities to establish expertise in basic, clinical, translational, and community research in domestic and international settings.
THE FUTURE OF INFECTIOUS DISEASES: COMPLETING THE PICTURE
Although ID has only been a formal specialty for <70 years, the field has matured into an exciting, dynamic, and joyful discipline to practice. It is hard to fully imagine what will happen over the next 70 years, but it seems likely that more and more patients will receive immunosuppressive treatments that impair host defenses significantly, resulting in illnesses similar to AIDS. The fields of oncology, rheumatology, dermatology, and neurology are increasingly relying on monoclonal antibodies that target key pathways in host defense. Bone marrow and solid organ transplants are becoming more prevalent and sophisticated. The incidence of other natural disease processes that affect host defenses, like diabetes, is increasing, and the ability to keep patients alive after suffering burns and trauma has improved substantially. And hepatitis C, once the purview of hepatologists, has moved into the realm of ID with the release of direct-acting agents. Taken together, the therapeutic disruption of host defenses will result in an ever-widening array of opportunistic processes, which will require the expertise of ID providers.
Overuse of antimicrobial therapy is leading to the emergence of highly resistant bacteria, creating a need for investigators focused on the development and testing of new drugs. Our ability to track outbreaks, both within hospital/clinic settings and globally generates opportunity to apply sophisticated, computerized epidemiologic approaches to direct interventions and stop emerging threats. The requirements by the Joint Commission to have AS programs and hospital epidemiology/ infection prevention programs create an immediate need for ID providers. The development of rapid, accurate, point-of-care diagnostics creates tremendous opportunities for determining the nature and cause of infections at the bedside, and ID-trained providers are needed to develop these new technologies and lead the way in their implementation. Finally, each of these emerging needs for ID expertise require translation and implementation into resource-poor environments worldwide.
The future of ID has never been brighter. The "ID color palette" is filled with vibrant tones of opportunity just waiting to be applied to the blank canvas by eager, curious, creative, and energized young physicians who create their own unique career path according to their own "artistic" vision.
What's missing is the critical mass of new "artists" entering the field of ID. The workforce assessments reveal, in stark reality, the emerging supply/demand mismatch. And while the bohemian lifestyle is attractive on many levels, the accompanying pay scale for services in ID remains lower than that for other medical subspecialties, mirroring the income of many "starving artists" on the Left Bank of Paris in 1884. What is different from 19th-century Paris, however, is the likely engagement of market forces that will bring payment for these essential services up to meet the demand, which seems to be growing exponentially as the clinical scenarios described above play out. For the specialty of ID, the time is now.
EPILOGUE
The second act of Sunday in the Park with George transitions to current time (1984) , with Georges Seurat's great-grandson, George, also an artist, presenting his work at a local museum. Young George feels disconnected to his work and that he is wasting his gifts. The play ends with George encountering an apparition of his great-grandmother, who advises him to stop overthinking his choices and simply make decisions based on his artistic, gut feelings. He then looks through a book handed down to him, inscribed with musings from his famous great-grandfather, which he reads aloud to the audience: "White: a blank page or canvas. His favorite-so many possibilities. "
Notes

